DNDi Market Share Analysis for April 2026

Established in 2003 in Geneva, Switzerland, DNDi’s global headquarters office is active in Research & Development activities, as well as in administrative and support departments, including finance, human resources, IT, policy advocacy, communications, and fundraising.

Health > Health Conditions and Concerns

Domaindndi.org

Year Founded2003

Employees201 - 500

Annual Revenue$5M - $10M

DNDi

DNDi (including company regionals)

dndi.org

See more website traffic and engagement information

DNDi Revenue up to April 2026 is 5M - 10M

revenue generated by DNDi top domains

DNDi top domains revenue over 3 years

Revenue for DNDi top domains

dndi.org5M - 10M

See more with Sales Intelligence

Total visits to DNDi's top domains

Understand DNDi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

dndi.org47.2K

See more with Sales Intelligence

Avg. visit duration in DNDi's top domains

Analyze DNDi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

dndi.org00:00:25

See more with Sales Intelligence

Avg. pageviews on DNDi's top domains

See how DNDi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

dndi.org1.78

See more with Sales Intelligence

DNDi top competitors by domain

Top similar sites in April 2026, ranked by their affinity

who.intCompany NameWorld Health Organization (WHO)Employees5001 - 10000HQSwitzerland, GenevaAnnual revenue> $1BTotal visits13MHealth > Health - Other

Top technologies used by DNDi

These are the website technologies, by industry, used by DNDi top domains

Payment & Currencies (24)

PayPal

Social (11)

Google+ Platform

Widget (7)

Twemoji

Conversion & Analytics (6)

Google Analytics

More Technologies

11

See all

News & Signals from DNDi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDrugs for Neglected Diseases Initiative is developing 4-in-1 treatment for infants and young children living with HIV.Following the development of its 4-in-1 treatment for infants and young children living with HIV, DNDi is advancing the development of a sustained-release formulation of flucytosine for cryptococcal meningitis, a life-threatening fungal infection and leading cause of death in people with advanced HIV.

NewsDrugs for Neglected Diseases Initiative is developing treatments that can cure river blindness, lymphatic filariasis, and schistosomiasis before they cause lasting harm.Drugs for Neglected Diseases Initiative is joining forces to develop new treatments that can cure river blindness, lymphatic filariasis, and schistosomiasis before they cause lasting harm - and working to make sure new treatments are suitable for all people who need them, including young children and pregnant women.

NewsDrugs for Neglected Diseases Initiative is developing acoziborole.Drugs for Neglected Diseases Initiative has finalized the development of acoziborole, a transformational new oral drug that can cure T.b. gambiense sleeping sickness in a single dose of three pills and may open the possibility of simplified 'test-and-treat' approaches in primary healthcare settings.